Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)
Clinical trial NCT07573436 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07573436
- Sponsor
- University of Utah
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.